Abstract:RNA splicing, a crucial transesterification-based process by which noncoding regions are removed from premature RNA to create mature mRNA, regulates various cellular functions, such as proliferation, survival, and differentiation. Clinical and functional studies over the past 10 y have confirmed that mutations in RNA splicing factors are among the most recurrent genetic abnormalities in hematologic neoplasms, including myeloid malignancies, chronic lymphocytic leukemia, mantle cell lymphoma, and clonal hematopoiesis. These findings indicate an important role for splicing factor mutations in the development of clonal hematopoietic disorders. Mutations in core or accessory components of the RNA spliceosome complex alter splicing sites in a manner of change of function. These changes can result in the dysregulation of cancer-associated gene expression and the generation of novel mRNA transcripts, some of which are not only critical to disease development but may be also serving as potential therapeutic targets. Furthermore, multiple studies have revealed that hematopoietic cells bearing mutations in splicing factors depend on the expression of the residual wild-type allele for survival, and these cells are more sensitive to reduced expression of wild-type splicing factors or chemical perturbations of the splicing machinery. These findings suggest a promising possibility for developing novel therapeutic opportunities in tumor cells based on mutations in splicing factors. Here, we combine current knowledge of the mechanistic and functional effects of frequently mutated splicing factors in normal hematopoiesis and the effects of their mutations in hematologic malignancies. Moreover, we discuss the development of potential therapeutic opportunities based on these mutations.

RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases

Alternative RNA Splicing in Fatty Liver Disease

The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease

RNA structure in alternative splicing regulation: from mechanism to therapy

Development and Disease-Specific Regulation of RNA Splicing in Cardiovascular System

RNA Structures in Alternative Splicing and Back‐splicing

Therapeutic potential of alternative splicing in cardiovascular diseases

<scp>RNA</scp> structures in alternative splicing and back‐splicing

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

Aberrant Regulation of Alternative Pre-Mrna Splicing in Hepatocellular Carcinoma.

Alternative splicing and related RNA binding proteins in human health and disease

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

RNA Splicing Alterations in Lung Cancer Pathogenesis and Therapy

Alternative Splicing: a Bridge Connecting NAFLD and HCC.

Targeting RNA-Splicing for SMA Treatment

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

RNA Splicing Factors in Normal Hematopoiesis and Hematologic Malignancies: Novel Therapeutic Targets and Strategies

Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Alternative splicing of gene transcription and its progress in clinical pharmacology

RNA mis-splicing in disease